Group Inc. Carlyle, a 10% owner of $QDEL ($QDEL), sold 8,260,183 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of...
The healthcare company has significant and untapped earnings potential, asserts one pundit.
The in vitro diagnostics company had a lot of bad news in its Q4 update.
/PRNewswire/ -- In an inspiring and emotional display of solidarity for Lyme disease awareness, a striking public service announcement (PSA) has taken center...
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...
It looks like the company's first quarter is going to please investors greatly.
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,...